Haynes Chloe J, Beck Alison K, Kelly Peter J, Lee Mei Lin, Stirling Robert, Hudson Suzie, Robinson Laura, Campbell Michele, Stubley Carolyn, Larance Briony
School of Psychology, University of Wollongong, Wollongong, Australia.
Network of Alcohol and Other Drug Agencies, Sydney, Australia.
Drug Alcohol Rev. 2025 Jul 7. doi: 10.1111/dar.70004.
The period post-residential treatment for opioid use is associated with heightened risk of overdose. The current study aims to: (i) describe characteristics of men and women attending residential treatment for primary opioid use; (ii) identify classes of clients based on primary opioid and other substance/s of concern and (iii) identify relationships between substance use profile and sociodemographic risk factors for opioid overdose, including differences by gender.
Data from 2994 clients (29.6% women) attending residential treatment for opioid use in the non-government sector in New South Wales, Australia, were included in the analysis. Descriptive and chi-square statistics analysed demographic, clinical, substance use and service use characteristics of participants. Participants were grouped using latent class analysis based on their primary opioid of concern and other substance/s of concern. Multinomial logistic regression examined the relationship between latent classes and sociodemographic risk factors for overdose, including interactions with gender.
Men and women presented to residential treatment with different demographic, clinical, substance use and service use characteristics. A five-class model of polysubstance use was identified: heroin + lower polysubstance use (52.3%), heroin + polysubstance use (22.2%), pharmaceutical + lower polysubstance use (10.1%), pharmaceutical + polysubstance use (6.7%) and OAT + polysubstance use (8.7%). There were some associations between sociodemographic risk factors and class membership, though limited interactions between sociodemographic risk and gender.
Effective overdose prevention and harm reduction strategies during and post-residential treatment need to consider individuals' complex and unique accumulation of risk.
阿片类药物使用的住院治疗后阶段与过量用药风险增加有关。本研究旨在:(i)描述因主要阿片类药物使用而接受住院治疗的男性和女性的特征;(ii)根据主要阿片类药物和其他相关物质确定客户类别;(iii)确定物质使用概况与阿片类药物过量的社会人口统计学风险因素之间的关系,包括性别差异。
分析了来自澳大利亚新南威尔士州非政府部门因阿片类药物使用而接受住院治疗的2994名客户(29.6%为女性)的数据。描述性统计和卡方统计分析了参与者的人口统计学、临床、物质使用和服务使用特征。根据参与者关注的主要阿片类药物和其他相关物质,使用潜在类别分析对参与者进行分组。多项逻辑回归分析了潜在类别与过量用药的社会人口统计学风险因素之间的关系,包括与性别的相互作用。
男性和女性在人口统计学、临床、物质使用和服务使用特征方面存在差异。确定了一个五类别多物质使用模型:海洛因+低多物质使用(52.3%)、海洛因+多物质使用(22.2%)、药品+低多物质使用(10.1%)、药品+多物质使用(6.7%)和阿片类药物替代治疗+多物质使用(8.7%)。社会人口统计学风险因素与类别归属之间存在一些关联,尽管社会人口统计学风险与性别之间的相互作用有限。
住院治疗期间及之后有效的过量用药预防和减少伤害策略需要考虑个体复杂且独特的风险累积情况。